Detailed price information for Os Therapies Incorporated (OSTX-A) from The Globe and Mail including charting and trades.
Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, ...
Expected in First Half of 2026, with Topline Data Expected in Second Half of 2026 On Track to Initiate Second Phase 3 Study, LEVEL-2, in 2025 Tenax to Host Virtual KOL Call Tomorrow, Thursday, ...
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial This ...
Better mental health, lowered risk of heart disease, and slimmer waistlines are all well-known health benefits of regular exercise. But a new study suggests some of the advantages gained by getting ...
Breathlessness intervention services (BIS), which coach patients to self-manage breathlessness using non-pharmacological ...
LEXINGTON, Ky. – The Kentucky Women’s Tennis program added three signees to help propel the future of the program, as announced by Head Coach Shelley Jaudon on Wednesday. Donna Le Roux signed an ...
Hospitals are at risk of becoming “overwhelmed” due to a significant rise in people needing urgent help with lung conditions, a charity has warned. Asthma and Lung UK said that over the last two years ...
NorthernIrelandWorld on MSN
Former bricklayer shares his brave battle with COPD to raise vital awareness of disease
Dominic McCourt arrives at Lagan Valley Hospital for his routine respiratory appointment, carrying what looks like a discreet lunch pack. But inside is something far more vital, his portable oxygen ...
Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with ...
PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis ...
Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback